Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

Leuk Res. 2009 Apr;33(4):565-6. doi: 10.1016/j.leukres.2008.05.006. Epub 2008 Jun 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminoglycosides / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Gemtuzumab
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / physiopathology
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Gemtuzumab